Hysterectomy Articles & Analysis
19 news found
Bernhard Krämer and their teams used Dexter in several surgical procedures including the removal of an ovarian cyst (cyst extirpation), the removal of an ovarian tumor (adnexectomy) and the removal of a patient’s uterus (hysterectomy). Robotic aid is a supplement in “keyhole surgery“ and a surgical robot is most useful for tasks like dissection and ...
Severe PPH cases can lead to debilitating outcomes for women, including emergency hysterectomy and death. Despite medical advancements, the incidence of PPH is increasing in Australia and in the USA maternal mortality associated with hemorrhage has remained stagnant over the last forty years. ...
The programme aims to significantly increase patient access to minimally invasive surgery which is associated with benefits including quicker recovery time, less scarring and less pain for patients. i It has already been used for over 50 successful cancer and benign cases at the clinic including nephrectomies, hysterectomies and hemicolectomies. Due to the small and modular ...
According to the study, the Senhance System was less than half the median instrument cost compared to procedures performed on another robotic platform and was comparable to traditional laparoscopic-assisted vaginal hysterectomy costs for certain gynecologic procedures. In May, a study was published which analyzed the outcomes of over 800 Senhance System procedures across ...
(Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that HCA Florida Healthcare’s Kendall Regional Medical Center, AdventHealth Celebration and The Women’s Hospital at Jackson Memorial have acquired the Hominis® Surgical System for use in single site, natural orifice laparoscopic-assisted ...
“Hominis is unique as it combines the advantages of transvaginal surgery, the preferred approach for hysterectomy, with the visual facility of laparoscopy and the ergonomic capabilities of robotic surgery, fulfilling an unmet need and presenting significant benefits to both clinicians and patients,” said Dr. ...
The Sonata Treatment is a breakthrough alternative to hysterectomy and myomectomy, and can treat a wider range of fibroid types, sizes, and locations than hysteroscopic myomectomy. ...
The Sonata Treatment is a breakthrough alternative to hysterectomy and myomectomy, and can treat a wider range of fibroid types, sizes, and locations than hysteroscopic myomectomy. ...
The Sonata Treatment is an alternative to hysterectomy and myomectomy, and can treat a wide range of fibroid types, sizes and locations. ...
“I look forward to contributing to Memic’s future growth and success building on the company’s first FDA-authorized indication of Hominis in women’s health including benign hysterectomy via the transvaginal approach. This technology has the potential to change patients’ ...
In granting Oli designation as a Breakthrough Device, the FDA recognises that Oli has the potential to save lives and reduce irreversible harm, such as from unplanned hysterectomies, that can be experienced by women as a result of postpartum haemorrhage. ...
The Sonata Treatment is a breakthrough alternative to hysterectomy and myomectomy, and can treat a wider range of fibroid types, sizes, and locations than hysteroscopic myomectomy. ...
The Sonata Treatment is a breakthrough alternative to hysterectomy and myomectomy, and can treat a wide range of fibroid types, sizes, and locations. ...
The Sonata Treatment is a breakthrough alternative to hysterectomy and myomectomy, and can treat a wider range of fibroid types, sizes, and locations than hysteroscopic myomectomy. ...
PPH is one of the most common complications of birth, resulting in pharmacologic treatment in up to 10% of mothers and potentially resulting in emergency intervention such as hysterectomy and blood transfusions, and, in some cases, maternal death.1 The transaction is expected to close after Organon has spun off from Merck as a standalone publicly traded company. ...
Food and Drug Administration (FDA) has granted De Novo marketing authorization of its Hominis® robot-assisted surgical platform for use in single site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures including benign hysterectomy. The De Novo authorization is supported by clinical data from procedures using the Hominis system on a variety of ...
Memic has successfully completed the first case in its Israeli study of transvaginal hysterectomy using the company’s innovative hominis® robotic-assisted surgical platform. ...
Jan Baekelandt of Bonheiden’s Imelda Hospital has performed a transvaginal robotic-assisted hysterectomy using Memic’s Hominis® technology. Dr. Baekelandt is a pioneering expert in gynecological oncology, and endoscopic and robotic surgery. ...
Others, even women who have had a tubal ligation or hysterectomy, either of which prevents the transfer of talc from the perineum to the ovary, would not be affected by talc application, scientists have confirmed. ...